Skip to content

Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome

Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04170686
Enrollment
146
Registered
2019-11-20
Start date
2019-10-28
Completion date
2020-09-28
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

cognitive behavioral therapy, self-help, irritable bowel syndrome

Brief summary

The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.

Interventions

BEHAVIORALZemedy App for Irritable Bowel Syndrome

The Zemedy App for irritable bowel syndrome is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.

Sponsors

Bold Health Inc.
CollaboratorINDUSTRY
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of IBS. Own a smart phone. Speak English

Exclusion criteria

* Under age of consent (18) Diagnosed with another GI disorder (e.g. celiac disease, inflammatory bowel disease)

Design outcomes

Primary

MeasureTime frameDescription
Irritable Bowel Syndrome Quality of Life8 weeksA self-report measure of health related quality of life (HRQL) in people with irritable bowel syndrome. Scores range from 0 to 100. Higher scores are a worse outcome.
Gastrointestinal Symptom Rating Scale8 weeksa self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.

Secondary

MeasureTime frameDescription
Fear of Food Questionnaire8 weeksself-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.
Patient Health Questionnaire8 weeksself-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.
Visceral Sensitivity Index8 weeksself-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.
Depression Anxiety and Stress Scale - Stress Subscale8 weeksThe stress subscale measures emotional reactivity to perceived stress. Scores range from 0-42 with higher scores representing worse stress reactivity.
Depression Anxiety and Stress Scale - Anxiety Subscale8 weeksMeasures affective and physical symptoms of anxiety. Scores range from 0-42 with higher scores representing worse anxiety.
Depression Anxiety and Stress Scale - Depression Subscale8 weeksSelf-report measure of depressive symptoms. Scores ranges from 0 to 42. Higher scores represent worse outcome.
GI Cognitions Questionnaire8 weeksself-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.

Countries

United States

Participant flow

Pre-assignment details

146 potential participants were consented and screened. 25 individuals met exclusion criteria (severe depression) and were not randomized.

Participants by arm

ArmCount
Immediate Treatment
Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace. Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.
62
Waitlist Control
Participants in the waitlist will receive no intervention for 8 weeks, other than a few check in emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.
59
Total121

Withdrawals & dropouts

PeriodReasonFG000FG001
Randomization and TreatmentLost to Follow-up2615
ScreeningPhysician Decision1213

Baseline characteristics

CharacteristicImmediate TreatmentWaitlist ControlTotal
Age, Continuous33.21 years
STANDARD_DEVIATION 10.1
30.71 years
STANDARD_DEVIATION 10.2
32 years
STANDARD_DEVIATION 10.2
Depression Anxiety and Stress Scale - Anxiety Subscale12.03 units on a scale
STANDARD_DEVIATION 7.35
13.19 units on a scale
STANDARD_DEVIATION 9.14
12.6 units on a scale
STANDARD_DEVIATION 8.25
Depression Anxiety and Stress Scale - Depression Subscale11.65 units on a scale
STANDARD_DEVIATION 9.88
15.59 units on a scale
STANDARD_DEVIATION 10.69
13.57 units on a scale
STANDARD_DEVIATION 10.43
Depression Anxiety and Stress Scale - Stress Subscale17.84 units on a scale
STANDARD_DEVIATION 9.56
18.71 units on a scale
STANDARD_DEVIATION 8.97
18.26 units on a scale
STANDARD_DEVIATION 9.25
Fear of Food Questionnaire52.87 units on a scale
STANDARD_DEVIATION 19.9
55.46 units on a scale
STANDARD_DEVIATION 18.2
54.13 units on a scale
STANDARD_DEVIATION 19.1
Gastrointestinal Symptom Rating Scale36.76 units on a scale
STANDARD_DEVIATION 12.77
37.75 units on a scale
STANDARD_DEVIATION 12.02
37.42 units on a scale
STANDARD_DEVIATION 12.4
GI Cognitions Questionnaire36.76 units on a scale
STANDARD_DEVIATION 12.77
37.75 units on a scale
STANDARD_DEVIATION 12.02
37.24 units on a scale
STANDARD_DEVIATION 12.4
Irritable Bowel Syndrome Quality of Life53.63 units on a scale
STANDARD_DEVIATION 18.67
60.48 units on a scale
STANDARD_DEVIATION 18.29
56.97 units on a scale
STANDARD_DEVIATION 18.7
Patient Health Questionnaire 98.32 units on a scale
STANDARD_DEVIATION 5.29
11.03 units on a scale
STANDARD_DEVIATION 4.66
9.64 units on a scale
STANDARD_DEVIATION 5.16
Race/Ethnicity, Customized
Asian
4 Participants1 Participants5 Participants
Race/Ethnicity, Customized
Black or African American
4 Participants2 Participants6 Participants
Race/Ethnicity, Customized
Hispanic
4 Participants3 Participants7 Participants
Race/Ethnicity, Customized
Multiple Race or Other
8 Participants3 Participants11 Participants
Race/Ethnicity, Customized
White
42 Participants50 Participants92 Participants
Region of Enrollment
United States
62 Participants59 Participants121 Participants
Sex: Female, Male
Female
49 Participants42 Participants91 Participants
Sex: Female, Male
Male
13 Participants17 Participants30 Participants
Visceral Sensitivity Index51.74 units on a scale
STANDARD_DEVIATION 12.29
53.54 units on a scale
STANDARD_DEVIATION 11.44
52.62 units on a scale
STANDARD_DEVIATION 11.9

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 620 / 59
other
Total, other adverse events
0 / 620 / 59
serious
Total, serious adverse events
0 / 620 / 59

Outcome results

Primary

Gastrointestinal Symptom Rating Scale

a self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentGastrointestinal Symptom Rating Scale27.56 score on a scaleStandard Deviation 10.12
Waitlist ControlGastrointestinal Symptom Rating Scale38.18 score on a scaleStandard Deviation 10.79
Primary

Irritable Bowel Syndrome Quality of Life

A self-report measure of health related quality of life (HRQL) in people with irritable bowel syndrome. Scores range from 0 to 100. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentIrritable Bowel Syndrome Quality of Life34.25 score on a scaleStandard Deviation 19.78
Waitlist ControlIrritable Bowel Syndrome Quality of Life58.19 score on a scaleStandard Deviation 18.53
Secondary

Depression Anxiety and Stress Scale - Anxiety Subscale

Measures affective and physical symptoms of anxiety. Scores range from 0-42 with higher scores representing worse anxiety.

Time frame: 8 weeks

Population: Treatment completers and waitlist control participants at post-treatment

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentDepression Anxiety and Stress Scale - Anxiety Subscale8.67 units on a scaleStandard Deviation 6.38
Waitlist ControlDepression Anxiety and Stress Scale - Anxiety Subscale12.05 units on a scaleStandard Deviation 9.72
Secondary

Depression Anxiety and Stress Scale - Depression Subscale

Self-report measure of depressive symptoms. Scores ranges from 0 to 42. Higher scores represent worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentDepression Anxiety and Stress Scale - Depression Subscale7.83 score on a scaleStandard Deviation 7.88
Waitlist ControlDepression Anxiety and Stress Scale - Depression Subscale15.45 score on a scaleStandard Deviation 10.39
Secondary

Depression Anxiety and Stress Scale - Stress Subscale

The stress subscale measures emotional reactivity to perceived stress. Scores range from 0-42 with higher scores representing worse stress reactivity.

Time frame: 8 weeks

Population: Treatment completers and waitlist control participants at post-treatment.

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentDepression Anxiety and Stress Scale - Stress Subscale12.72 units on a scaleStandard Deviation 8.65
Waitlist ControlDepression Anxiety and Stress Scale - Stress Subscale18.82 units on a scaleStandard Deviation 9.99
Secondary

Fear of Food Questionnaire

self-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentFear of Food Questionnaire41.22 score on a scaleStandard Deviation 22.23
Waitlist ControlFear of Food Questionnaire53.75 score on a scaleStandard Deviation 18.08
Secondary

GI Cognitions Questionnaire

self-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentGI Cognitions Questionnaire22.44 score on a scaleStandard Deviation 13.72
Waitlist ControlGI Cognitions Questionnaire40.84 score on a scaleStandard Deviation 11.23
Secondary

Patient Health Questionnaire

self-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentPatient Health Questionnaire5.78 score on a scaleStandard Deviation 4.2
Waitlist ControlPatient Health Questionnaire10.32 score on a scaleStandard Deviation 4.29
Secondary

Visceral Sensitivity Index

self-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Immediate TreatmentVisceral Sensitivity Index38.14 score on a scaleStandard Deviation 16.21
Waitlist ControlVisceral Sensitivity Index53.57 score on a scaleStandard Deviation 12.37

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026